| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | Director | Common Stock | 24,444 | $577,611 | $23.63 | 01 Jan 2026 | Direct |
| AMICUS THERAPEUTICS, INC. | Director | Common Stock | 84,631 | $525,558 | $6.21 | 05 Jun 2025 | Direct |
| Apellis Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 14,684 | $513,149 | $18.20 | 01 Jan 2026 | Direct |
| AMICUS THERAPEUTICS, INC. | Director | Stock Options (right to buy) | 74,872 | 05 Jun 2025 | Direct | ||
| AMICUS THERAPEUTICS, INC. | Director | Stock Options (right to buy) | 42,467 | 06 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 01 Jan 2026 | 2 | $0 | 4 | Director | 05 Jan 2026, 16:34 |
| FOLD | AMICUS THERAPEUTICS, INC. | 05 Jun 2025 | 2 | $0 | 4 | Director | 06 Jun 2025, 16:47 |
| APLS | Apellis Pharmaceuticals, Inc. | 17 Apr 2025 | 2 | +$513,149 | 4 | Director | 21 Apr 2025, 16:23 |
| APLS | Apellis Pharmaceuticals, Inc. | 17 Apr 2025 | 0 | $0 | 3 | Director | 21 Apr 2025, 16:09 |
| FOLD | AMICUS THERAPEUTICS, INC. | 06 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 19:53 |
| FOLD | AMICUS THERAPEUTICS, INC. | 08 Jun 2023 | 2 | $0 | 4 | Director | 12 Jun 2023, 17:35 |
| FOLD | AMICUS THERAPEUTICS, INC. | 09 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:14 |
| FOLD | AMICUS THERAPEUTICS, INC. | 10 Jun 2021 | 2 | $0 | 4 | Director | 14 Jun 2021, 19:07 |